Balchem Balance Sheet Health
Financial Health criteria checks 4/6
Balchem has a total shareholder equity of $1.1B and total debt of $309.6M, which brings its debt-to-equity ratio to 29.4%. Its total assets and total liabilities are $1.6B and $543.2M respectively. Balchem's EBIT is $156.9M making its interest coverage ratio 6.9. It has cash and short-term investments of $64.4M.
Key information
29.4%
Debt to equity ratio
US$309.57m
Debt
Interest coverage ratio | 6.9x |
Cash | US$64.45m |
Equity | US$1.05b |
Total liabilities | US$543.23m |
Total assets | US$1.60b |
Recent financial health updates
These 4 Measures Indicate That Balchem (NASDAQ:BCPC) Is Using Debt Reasonably Well
Feb 18Balchem (NASDAQ:BCPC) Has A Pretty Healthy Balance Sheet
Oct 19Is Balchem (NASDAQ:BCPC) A Risky Investment?
Jul 19We Think Balchem (NASDAQ:BCPC) Can Stay On Top Of Its Debt
Mar 14Is Balchem (NASDAQ:BCPC) A Risky Investment?
Dec 13Balchem (NASDAQ:BCPC) Seems To Use Debt Rather Sparingly
Sep 05Recent updates
Balchem Corporation's (NASDAQ:BCPC) Popularity With Investors Is Clear
Mar 21Is Balchem Corporation (NASDAQ:BCPC) Expensive For A Reason? A Look At Its Intrinsic Value
Mar 05Balchem: Potential Turnaround Is In The Price
Feb 21These 4 Measures Indicate That Balchem (NASDAQ:BCPC) Is Using Debt Reasonably Well
Feb 18Returns On Capital At Balchem (NASDAQ:BCPC) Have Stalled
Jan 03Balchem Corporation's (NASDAQ:BCPC) P/E Is On The Mark
Dec 19Estimating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)
Nov 20Balchem (NASDAQ:BCPC) Has A Pretty Healthy Balance Sheet
Oct 19The Returns At Balchem (NASDAQ:BCPC) Aren't Growing
Sep 09A Look At The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)
Aug 22Is Balchem (NASDAQ:BCPC) A Risky Investment?
Jul 19Some Investors May Be Worried About Balchem's (NASDAQ:BCPC) Returns On Capital
May 28Calculating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)
May 12Do Balchem's (NASDAQ:BCPC) Earnings Warrant Your Attention?
Apr 12We Think Balchem (NASDAQ:BCPC) Can Stay On Top Of Its Debt
Mar 14Balchem (NASDAQ:BCPC) Hasn't Managed To Accelerate Its Returns
Jan 11Here's Why We Think Balchem (NASDAQ:BCPC) Is Well Worth Watching
Dec 29Is Balchem (NASDAQ:BCPC) A Risky Investment?
Dec 13Balchem Corporation (NASDAQ:BCPC) Shares Could Be 26% Above Their Intrinsic Value Estimate
Nov 29Here's What To Make Of Balchem's (NASDAQ:BCPC) Decelerating Rates Of Return
Sep 20Balchem: Acquisitions And Cost Pressures Draw Attention
Sep 12Balchem (NASDAQ:BCPC) Seems To Use Debt Rather Sparingly
Sep 05Balchem to acquire Cardinal Associates or Bergstrom Nutrition
Aug 30Is Balchem Corporation (NASDAQ:BCPC) Worth US$138 Based On Its Intrinsic Value?
Aug 22Should You Be Adding Balchem (NASDAQ:BCPC) To Your Watchlist Today?
Aug 08Balchem Q2 2022 Earnings Preview
Jul 28Balchem: On The M&A Road Again
Jun 28Balchem: A New Growth Stage Is Just Beginning
Jun 02Slowing Rates Of Return At Balchem (NASDAQ:BCPC) Leave Little Room For Excitement
May 30Balchem Corporation's (NASDAQ:BCPC) Intrinsic Value Is Potentially 17% Below Its Share Price
May 18Does Balchem (NASDAQ:BCPC) Deserve A Spot On Your Watchlist?
May 02Does Balchem (NASDAQ:BCPC) Have A Healthy Balance Sheet?
Mar 28Balchem (NASDAQ:BCPC) Hasn't Managed To Accelerate Its Returns
Feb 26Balchem (NASDAQ:BCPC) Could Easily Take On More Debt
Dec 23Return Trends At Balchem (NASDAQ:BCPC) Aren't Appealing
Nov 18We Think Balchem (NASDAQ:BCPC) Can Manage Its Debt With Ease
Sep 22Here's What To Make Of Balchem's (NASDAQ:BCPC) Decelerating Rates Of Return
Aug 16Balchem: Good Quarterly Performance Priced In
Aug 02These 4 Measures Indicate That Balchem (NASDAQ:BCPC) Is Using Debt Safely
Jun 12Returns On Capital At Balchem (NASDAQ:BCPC) Have Stalled
May 13Balchem EPS beats by $0.03, beats on revenue
Apr 30Balchem: All Eyes On M&A And Autism Drug
Apr 26Is Balchem (NASDAQ:BCPC) A Risky Investment?
Mar 14How Many Balchem Corporation (NASDAQ:BCPC) Shares Have Insiders Sold, In The Last Year?
Feb 27Financial Position Analysis
Short Term Liabilities: BCPC's short term assets ($314.2M) exceed its short term liabilities ($148.5M).
Long Term Liabilities: BCPC's short term assets ($314.2M) do not cover its long term liabilities ($394.7M).
Debt to Equity History and Analysis
Debt Level: BCPC's net debt to equity ratio (23.3%) is considered satisfactory.
Reducing Debt: BCPC's debt to equity ratio has increased from 22.6% to 29.4% over the past 5 years.
Debt Coverage: BCPC's debt is well covered by operating cash flow (59.4%).
Interest Coverage: BCPC's interest payments on its debt are well covered by EBIT (6.9x coverage).